baber/WOPTO huggingface dataset:
Patent NZ-545342-A (NZ)
Title: Intramedullary nail
Inventor: FRIGG ROBERT
IPC: A61B17/72
Filed: 2003-08-29
Abstract: Disclosed is an intramedullary nail (1) comprising a longitudinal axis (2), a proximal end (not shown), a distal end (4), at least one bore (10, 11) that extends perpendicular to the longitudinal axis (2), lies on a plane (20), and has a defined diameter (d10, d11) for accommodating a locking element (12, 13), and a longitudinal slot (9) that runs parallel to the longitudinal axis (2) on said plane (20). The longitudinal slot (9) is provided with a width b which is measured perpendicular to the plane (20) in the area outside the bores (10, 11) in the non-expanded state of the intramedullary nail and corresponds to a maximum of .6 times the smallest defined diameter (d10) of the bores (10, 11). The distal end has either a closed slot (not shown in this view) or is otherwise constructed so as to limit the amount of expansion of the slot in use.
Patent NZ-547753-A (NZ)
Title: A process and apparatus for green body extrusion
Inventor: STANG HENRIK
IPC: B28B3/24
Filed: 2004-11-17
Abstract: In a process and apparatus for the extrusion of a green body from a paste or suspension of particulate material in a liquid, the suspension is supplied to and substantially fills an extrusion chamber at a low pressure of less than 20 bar. A high pressure of at least 80 bar is applied to the suspension on completion of filling whereby the suspension is forced through a moulding spaced with a dewatering section defined by at least partially liquid-permeable walls. A substantial part of the liquid is removed by establishing a pressure differential across at least parts of the wall that are permeable to said liquid, to form a non-flowable shaped body of the particulate material.
Patent NZ-548027-A (NZ)
Title: A novel protein capable of inhibiting anthrax toxin activity
Inventor: ARORA NAVEEN
Filed: 2003-12-05
Abstract: Disclosed is the use of a protein isolated from the pollen grains of grass species selected from the group consisting of Imperata cylindrical, Lolium perenne, Phleum pratense and Cynodon dactylon with the following characteristics of being; hydrophobic,67kDa, stable at room temperature, resistant to trypsin, inhibits cleavage of protective antigen of B. anthracis in a dose dependant manner, binds to IgE and the protein being devoid of any carbohydrate moiety in the manufacture of a medicament for the treatment of anthrax wherein the protein is capable of inhibiting anthrax toxin activity.
Patent NZ-548740-A (NZ)
Title: HCV NS-3 Serine protease inhibitors
Inventor: ROSENQUIST ASA
IPC: C07D/
Filed: 2005-01-28
Abstract: Disclosed are compounds of the formula VI, which are inhibitors of the NS3 serine protease of the flavivirus HCV; wherein A is C(=O)OR1, or C(=O)NHSO2R2; p is independently 1 or 2; M is CR7R7'; Ru is H or C1-C3alkyl; q' is 0 or 1 and k is 0 to 3; Rz is H, or together with the asterisked carbon forms an olefinic bond; Rq is H or C1-C6alkyl; W is -CH2-, -O-, -C(=O)NH-, -OC(=O)-, -S-, -NH-, -NRa-, -NHSO2-, -NHC(=O)NH- or -NHC(=O)-, -NHC(=S)NH- or a bond; R8 is a ring system containing 1 or 2 saturated, partially saturated or unsaturated rings; Rx is H or C1-C5alkyl; or Rx is J; T is -CHR11- or -NRd-, where Rd is H, C1-C3alkyl or J; m is 0 or 1; n is 0 or 1; U is O or is absent; R15 and R16 are independently H, C1-C6alkyl, C0-C3alkylcarbocyclyl, C0-C3alkylheterocyclyl; G is -O-, -NRy-, -NRjNRj-; or a pharmaceutically acceptable salt thereof. Also disclosed is a pharmaceutical composition comprising a compound as defined above and a pharmaceutically acceptable carrier therefor, which may further comprise an additional HCV antiviral, selected from nucleoside analogue polymerase inhibitors, protease inhibitors, ribavirin and interferon.
Patent NZ-548994-A (NZ)
Title: Perforated sheeting
Inventor: GIBSON SCOTT IAN
Filed: 2006-08-04
Abstract: Insulating sheeting comprising a body (10) having a pair of opposed surfaces (14), the body comprising an insulating cell structure (13) and an outer insulating layer (11) adjacent the cell structure, the outer layer defining one of the opposed surfaces. The body contains perforations (25) extending through the body between the opposed surfaces to provide permeability to water vapour.
Patent NZ-549167-A (NZ)
Title: Seed treatment pesticidal compositions
Inventor: LOPEZ HUMBERTO B
IPC: A01N43/90
Filed: 2005-03-15
Abstract: Disclosed is an aqueous seed treatment insecticidal and/or nematicidal composition in the form of a suspension comprising (A) at least one insecticide and/or nematicide in an amount of at least 3 weight %, based on the total weight of the composition, and (B) at least two surface active compounds, wherein at least one is an anionic phosphate type compound, and at least one is a non-ionic alkoxylated phenol.
Patent NZ-549181-A (NZ)
Title: Method & device for monitoring blood pressure
Inventor: TING CHOON MENG
IPC: A61B5/022
Filed: 2003-07-09
Abstract: A device for non-invasive continuous monitoring of a user's arterial blood pressure that is capable of being used as an ambulatory beat-to-beat blood pressure monitor (ABMP) including: sensing means adapted to continuously detect the blood pressure and to generate signals representative thereof by contact with an external surface of the user's body at a location adjacent an artery; microprocessing means for interpreting the signals generated by the sensing means to determine actual arterial blood pressure, the microprocessing means being programmed to record a complete and continuous arterial pulse waveform; a first housing holding the sensing means; a second housing enclosing the microprocessing means; and at least one strap connecting the first housing and the second housing and together therewith forming a band to encircle the wrist of a wearer, the first housing having an outwardly facing pressure surface, with at least one the strap passing freely over the pressure surface. (62) Divided Out of 537664
Patent NZ-551661-A (NZ)
Title: Guanidino acetic acid used as an animal food additive
Inventor: GASTNER THOMAS
IPC: A23K50/75
Filed: 2005-06-07
Abstract: The disclosure relates to the use of guanidinoacetic acid or the salts thereof as feed additive for breeding and growing livestock in predominantly vegetarian diets to improve feed uptake, to increase growth performance, muscle meat gain, meat quality or reproduction performance. The feed additive can also be used in combination with salts of hydrochloric acid, hydrogen bromide acid and phosphoric acid. Further disclosed is the use of the guanidinoacetic acid in individual doses of 0.01 to 100 g/kg in the form of powder, granulates, pellets or capsules.
Patent NZ-556713-A (NZ)
Title: Biostatic polymer
Inventor: KRITZLER STEVEN
IPC: C09D129/04
Filed: 2006-02-02
Abstract: Disclosed is a method effective for at least for prevention of microbial colony growth on an inanimate surface which is a plastic, metal or ceramic surface, comprising the step of covering the surface with a dry or substantially dry film formed from a composition comprising a polyvinyl alcohol and a quaternary ammonium compound and surfactant which does not inactivate the quaternary compound. Also disclosed is a composition effective for at least a week for prevention of microbial colony growth on an inanimate surface which is a plastic, metal, glass or ceramic surface comprising a complex formed between a polyvinyl alcohol, and a quaternary ammonium compound and a surfactant which does not inactivate the quaternary compound.
Patent NZ-563066-A (NZ)
Title: Soluble coffee product
Inventor: BEL-RHLID RACHID
Filed: 2006-04-28
Abstract: Disclosed is a coffee product derived from roast and ground coffee beans that has reduced levels of chlorogenic acid lactones relative to the levels of chlorogenic acids. The product can be prepared by treating a coffee extract with an enzyme so as to hydrolyse at least a portion of the chlorogenic acid lactones present in the extract. The product has reduced bitterness.
Patent NZ-566487-A (NZ)
Title: Modular flooring assemblies
Inventor: MCINTOSH JONATHAN
IPC: E04B2/08
Filed: 2006-10-03
Abstract: A component of a flooring system comprising a flooring component, an adhesive, a tray substrate 100 having a tray substrate 100 surface which is an upward facing horizontal surface, a tray substrate 100 bottom with a padding 500 attached to the tray substrate 100 bottom, a plurality of tray substrate 100 vertical tray edges which protrude upward and extend around a perimeter of the tray substrate 100 surface a plurality of tray substrate 100 edges defining an outside perimeter of the tray substrate 100, the tray substrate 100 edges having a plurality of upward tabs and downward tabs with the upward tabs and the downward tabs extending alternatively from the plurality of the tray substrate 100 edges, wherein the upward tabs each have a convex surface and a valley, and the downward tabs each have a concave surface and a lip, wherein the flooring component is smaller than a tray surface defined by the tray substrate 100 vertical edges and the flooring component is adhered to the tray substrate 100 surface with the adhesive, further comprising a plurality of grout holders each having an angled shape that widens towards the bottom of the tray substrate 100, with the grout holders located between the altering upward tabs and downward tabs.
Patent NZ-567046-A (NZ)
Title: Use of k-casein for promoting glucagon-like peptide 1 secretion and for the manufacture of a medicament for the treatment of diabetes or hyperglycemia
Inventor: ITOH YOUSUKE
IPC: A61K38/17
Filed: 2006-09-29
Abstract: Disclosed is the use of k-casein for the manufacture of a medicament for the treatment or prevention or diabetes or hyperglycemia.
Patent NZ-570358-A (NZ)
Title: Tamper resistant dosage forms
Inventor: FLEISCHER WOLFGANG
IPC: A61K9/22
Filed: 2007-01-25
Abstract: Disclosed is a method for preventing the formation of a certain extract of a controlled release matrix formulation comprising a therapeutic amount of an opioid agonist and an opioid antagonist in an amount at least sufficient to substantially antagonize the therapeutic amount of opioid agonist, when both, the opioid agonist and the opioid antagonist, are administered intravenous at the same time, when the controlled release matrix formulation is subjected to a one step extraction procedure comprising the steps of: (a) crushing the formulation of one dosage form using a pill crusher or a tablet mortar, or using two spoons, wherein the crushing is performed at least 4 times using the spoons; (b) extracting the crushed formulation of one dosage form on a spoon using 2 ml boiling tap water as extracting agent and a cigarette lighter as heating means for a time period that is necessary to boil the water; and (c) filtering the solution using cotton; wherein the opioid antagonist is present in said extract to be prevented in a weight percent amount, based on the total amount of opioid antagonist in the dosage form, that is more than 20 %-points less than the weight percent amount of opioid agonist present in the extract, based on the total amount of opioid agonist in the dosage form, and wherein the opioid agonist is oxycodone hydrochloride and the opioid antagonist is naloxone hydrochloride which are present in dosage form in an amount ratio of 2:1,by forming a controlled release dosage form comprising a homogeneous controlled release matrix formulation comprising a hydrophobic material, including at least one hydrophobic polymer being ethyl cellulose and at least one fatty alcohol or fatty acid, being a C12 to C36 aliphatic alcohol or acid and said therapeutic amount of opioid agonist and said sufficient amount of opioid antagonist.
Patent NZ-570473-A (NZ)
Title: Structural stud
Inventor: VALLE JOHN
IPC: E04C3/07
Filed: 2007-02-09
Abstract: A structural stud 201 comprises a stud with a web 203 and a sidewall 205. Vertical and horizontal tabs 207, 215, 209, 217 are punched out of the sidewall 205, leaving vertical and horizontal holes 211, 219, 213, 221. The vertical and horizontal tabs 207, 215, 209, 217 each comprise a tab leg 223, 225 and a tab foot 227, 239, 229, 241. The tab leg 223, 225 is substantially planar, is connected to the sidewall 205 at one end, and projects outwardly from the sidewall 205 at an angle of less than ninety degrees to the sidewall 205. A tab foot 227, 239, 229, 241 extends from the free end of the tab 207, 215, 209, 217 and curves either away from or toward the web 203. The end of the vertical tab leg 207, 209 that is connected to the sidewall 205 is substantially perpendicular to the end of the horizontal tab leg that is connected to the sidewall 205.
Patent NZ-572765-A (NZ)
Title: Automatic injection device with rod driving syringe longitudinally split with radially compressible pair of wings along its length
Inventor: JULIAN JOSEPH F
IPC: A61M5/315
Filed: 2007-06-29
Abstract: An automatic injection device is for providing a subcutaneous injection of a substance into a user, comprising a housing; a syringe movably disposed in the housing, the syringe including a barrel portion for holding the substance; a hollow needle; a bung; a plunger for moving the syringe such that the needle projects from the housing and for subsequently applying pressure to the bung; a compressible expanded central portion; a flange; and a biasing mechanism. Also disclosed are methods and kits for using an automatic injection device, and methods and kits for promoting an automatic injection device comprising a medication based on advantageous properties of the device as compared to a pre-filled syringe. There is also provided methods and kits for training a recipient on use of the automatic injection device.
Patent NZ-578608-A (NZ)
Title: A tensioning mechanism for use with a growing assembly where the tension of a flexible support is adjusted by the movement of a first member
Inventor: FLOWERDAY WILLIAM VINCENT
IPC: A01G17/06
Filed: 2010-09-28
Abstract: A tensioning mechanism for use with a growing assembly 1, where the growing assembly 1 includes a structure having a length and a width, and a flexible support 19A extends along the structure's length. The tensioning mechanism includes a first member 10 that is connected to the flexible support 19A at a point, where the first member 10 is secured to a first reference point so as to be able to move through a range of movement between a first position and a second position. The range of movement of the first member 10 causes the point on the member 10 to move along the length of the structure such that in the first position the first member 10 tensions the flexible support 19A while in the second position the tension in the flexible support 19A is less than in the first position.
Patent NZ-583765-A (NZ)
Title: Irrigation system and adding carbon dioxide
Inventor: LLOYD ROBERT
IPC: A01G25/16
Filed: 2008-08-08
Abstract: An irrigation system 10g comprising a hollow tube 210, a temperature controller 160 or a temperature adjustor, a carbon dioxide injector 100 or a dosing device, a control unit 40 and one or more carbon dioxide sensors. The tube 20, 210 has a tube wall 220 with pores 250 extending through it. The tube wall 220 defines a tube interior 230 from which water can pass through the tube wall 220 via the pores 250. The temperature controller 160 will control the temperature of the water. If a temperature adjustor is used instead it will adjust the temperature of the water. The carbon dioxide injector 100 will inject a gas containing carbon dioxide into the water before the water passes out of the tube 20, 210. If the dosing device is used instead, it will add a substance capable of releasing carbon dioxide into the water before the water passes out of the tube 20, 210. The control unit 40 will adjust one or more of the following parameters - the temperature of the water, the rate of injecting carbon dioxide into the water and the rate of addition to the water of the substance capable of releasing carbon dioxide and pH of the water. The one or more carbon dioxide sensors are located downstream of the injector or dosing device. The sensors will send a signal relating to carbon dioxide concentration in the water to the control unit.
Patent NZ-583920-A (NZ)
Title: Antenna arrangement with a resonator and filter means
Inventor: SAVOLAINEN RISTO KALEVI
IPC: H01Q1/24
Filed: 2006-10-18
Abstract: Disclosed is a method of passing signals within a wireless communication system, and an antenna arrangement used to carry out the method. The method includes the steps of: receiving a signal from the wireless communication system; transmitting the signal to a resonator and to a filter; receiving, by the resonator and the filter the signal; passing, by the resonator, frequencies of the signal to a receiver within a frequency range of the receiver; passing, by the filter, frequencies of the signal to a module ground below the frequency range of the receiver; receiving, by the module ground, frequencies of the signal from the filter; passing, by the module ground, frequencies of the signal to the receiver; and receiving, by the receiver frequency of the interest from the resonator and from the module ground. (62) Divided Out of 567518
Patent NZ-584614-A (NZ)
Title: Method of separating embryo suspension mass
Inventor: PALTIEL-ZUCATI JUDITH N
IPC: A01H4/00
Filed: 2008-09-22
Abstract: Disclosed is a method of separating an embryo suspension mass, the method comprising: supplying an embryo suspension mass culture having a plurality of first particles of a first size and a plurality of second particles of a second size different at least in part from the first size of the first particles; suspending the embryo suspension mass culture in a fluid to create a mixture; and forcing the mixture through at least a first filter while maintaining the mixture in the fluid to separate the first particles from the second particles. Further disclosed is a method of separating an embryo suspension mass, the method comprising: supplying an embryo suspension mass culture having a plurality of first particles of a first size and a plurality of second particles of a second size different at least in part from the first size of the first particles; suspending the embryo suspension mass culture in a fluid to create a mixture; and applying a rotary motion to the mixture to force the mixture through a filter to separate the first particles from the second particles. Further disclosed is a method of separating an embryo suspension mass, the method comprising: supplying an embryo suspension mass culture having a plurality of first particles of a first size and a plurality of second particles of a second size different at least in part from the first size of the first particles; depositing the embryo suspension mass culture in a basket having a plurality of pores sized to filter at least the first particles from the second particles; suspending the basket containing the embryo suspension mass culture in a fluid to create a mixture; and applying a rotary motion to the mixture to force the mixture through the plurality of pores of the basket to separate the first particles from the second particles.
Patent NZ-586025-A (NZ)
Title: Rasagiline mesylate tablet coated with a composisiton comprising methacrylic acid - ethyl acrylate copolymer and triethyl citrate
Inventor: SAFADI MUHAMMAD
IPC: A61K31/135
Filed: 2009-01-09
Abstract: A tablet comprising: a core comprising rasagiline mesylate and at least one pharmaceutically acceptable excipient; and an acid resistant pharmaceutically acceptable coating, wherein said acid resistant pharmaceutically acceptable coating comprises methacrylic acid - ethyl acrylate copolymer (1:1) and a plasticizer and in the coating, the ratio of methacrylic acid - ethyl acrylate copolymer (1:1) to plasticizer by weight is 5 to 1, wherein the plasticizer is triethyl citrate; and wherein said tablet releases the following percentages of rasagiline mesylate when placed in a basket apparatus in 500 mL of buffered aqueous media at 37°C at 75 revolutions per minute for 60 minutes under the following pH conditions: a) 0% in 0.1 N HCl; b) between 0 and 20% in a phosphate buffer solution with a pH of 6.0. And further the Use of the tablet of any one of the tablet in the manufacture of a medicament for treating a patient suffering from Parkinson's disease
Patent NZ-586280-A (NZ)
Title: Oral pharmaceutical composition comprising FTY720 and mannitol
Inventor: OOMURA TOMOYUKI
IPC: A61K31/137
Filed: 2004-04-06
Abstract: Disclosed is a pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor agonist; and (b) mannitol, wherein the composition is a solid form dosage, the mannitol has a high specific surface area and the S1P receptor agonist is selected from 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol (FTY720), a pharmaceutically acceptable salt thereof, and FTY720-phosphate. The disclosed pharmaceutical composition is suitable for the prevention or treatment of organ or tissue transplant rejection, or for treating an autoimmune disease or inflammatory condition, viral myocarditis or viral disease caused by viral myocarditis or for the treatment of multiple sclerosis.
Patent NZ-589258-A (NZ)
Title: Cam-actuated pneumatic switch mechanism system for controlling the timed spacing of fasteners driven from hand-held fastener-driving tools
Inventor: CORTEZ GENARO
IPC: B27F7/00
Filed: 2009-05-05
Abstract: 589258 Disclosed is a fastener-driving tool (100) that has a cam-actuated pneumatic switch (116) mechanism system operatively incorporated thereon which is adapted to control the timed driving or discharge of fasteners out from a hand-held fastener-driving tool and into a substrate at predeterminedly spaced positions with respect to each other. The arrangement is particularly adapted for use in connection with the driving of fasteners into corner regions of structural workpieces, although the same may also be used to drive fasteners into flat planar surfaces.
Patent NZ-591250-A (NZ)
Title: Plastic bag with a bonded or extruded reinforcing strip along the bottom edge
Inventor: WILCOXEN KYLE R
IPC: B31B50/10
Filed: 2009-08-21
Abstract: 591250 Disclosed is a plastic bag with flexible sidewalls defining an interior volume for holding contents, which includes a reinforcing feature to resist puncture and/or rupture of the bag. The reinforcing feature includes reinforcing the bottom edge of the bag with additional or thicker thermoplastic material. The reinforcing strip of plastic material is attached along a bottom edge of the bag, either internally or externally, to provide additional material resistant to puncture. Or the sheet material used to produce the bag is made with a thicker band that is folded to produce the bottom edge.
Patent NZ-591797-A (NZ)
Title: Fluid dispensing system with a pressure regulation or bleed valve having a membrane covered throat connected to a container aperture
Inventor: ARCURI JOSEPH F
IPC: B65D83/00
Filed: 2007-01-30
Abstract: Disclosed is a fluid dispensing system containing a pressure bleed valve so that the container cannot be stored holding an elevated pressure for an extended period of time. The fluid dispensing system has a container and a pump connected to the container for pressurizing the container. A bleed valve has a throat in communication with an aperture formed through the container and a membrane positioned in interiorly of and in covering relation to the throat. The outlet port has a check valve associated with the pump, and a discharge conduit having a single use connector engaging the outlet port and displacing the check valve to a flow position. The single use connector fails under a load precluding operable re-engagement with the outlet in a failed state. The bleed valve is configured to bleed-off excess pressure in the container over a period of from 12 hours to 24 hours.